Zentalis Pharmaceuticals (ZNTL) Tax Provisions (2019 - 2026)
Zentalis Pharmaceuticals (ZNTL) recorded quarterly Tax Provisions of $120000.0 in Q1 2026, down 72.85% quarter-over-quarter from $442000.0 in Q4 2025.
Zentalis Pharmaceuticals (ZNTL) Tax Provisions (2019 - 2026) Analysis & Trends
Zentalis Pharmaceuticals' Tax Provisions history runs 8 years deep, the most recent figure standing at $120000.0 for Q1 2026.
- In Q1 2026, Tax Provisions changed N/A year-over-year to $120000.0; the TTM figure through Mar 2026 stood at $562000.0 (up 1552.94% YoY), while the FY2025 annual figure was $442000.0, up 149.72% from the prior year.
- Tax Provisions was $120000.0 for Q1 2026 at Zentalis Pharmaceuticals, down from $442000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $442000.0 in Q4 2025 to a low of -$605000.0 in Q2 2023.
- Historically, Tax Provisions has averaged -$23642.9 across 5 years, with a median of $24000.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Tax Provisions tumbled 3658.82% in 2023, then jumped 315.61% in 2025.
- A 5-year view of Tax Provisions shows it stood at -$360000.0 in 2022, then surged by 62.5% to -$135000.0 in 2023, then plunged by 51.85% to -$205000.0 in 2024, then surged by 315.61% to $442000.0 in 2025, then sank by 72.85% to $120000.0 in 2026.
- The last three Tax Provisions figures came in at $120000.0 (Q1 2026), $442000.0 (Q4 2025), and -$205000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Zentalis Pharmaceuticals | 260.33 Mn | 260.33 Mn | - | 120,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 120,000.00 |
| Dec 31, 2025 | 442,000.00 |
| Dec 31, 2024 | -205,000.00 |
| Sep 30, 2024 | -27,000.00 |
| Jun 30, 2024 | 266,000.00 |
| Mar 31, 2024 | 143,000.00 |
| Dec 31, 2023 | -135,000.00 |
| Sep 30, 2023 | 31,000.00 |
| Jun 30, 2023 | -605,000.00 |
| Mar 31, 2023 | 108,000.00 |
| Dec 31, 2022 | -360,000.00 |
| Sep 30, 2022 | -159,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Mar 31, 2022 | 33,000.00 |
| Dec 31, 2021 | 159,000.00 |
| Sep 30, 2021 | -697,000.00 |
| Jun 30, 2021 | 45,000.00 |
| Mar 31, 2021 | 196,000.00 |
| Dec 31, 2020 | 426,000.00 |
| Sep 30, 2020 | 18,000.00 |